drugset / Trial / NCT02198339
Efficacy, Safety, Tolerability and Pharmacokinetics of BIBN 4096 BS Versus Placebo in the Treatment of a Single Attack of Acute Migraine Headache
RandomizedParallel-groupDouble-blindTreatment
Summary
Efficacy, Safety, Tolerability and Pharmacokinetics of BIBN 4096 BS in patients with a single acute migraine attack with or without aura
Timeline
- Start
- 1999-02
- Primary completion
- 1999-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | OLCEGEPANT | Small molecule | 0.1 mg | Intravenous |
| Subject | OLCEGEPANT | Small molecule | 10 mg | Intravenous |